Table 1.
Chemotherapy/Targeted Therapy Type | Examples of Specific Medications | Cardiovascular Side Effects | Role of Cardiac CT |
---|---|---|---|
Fluoropyrimidines | 5-FU Capecitabine |
Anginal chest pain (incidence up to 18%) (55,56,105, 106, 107, 108) more common with infusion of 5-FU Coronary vasospasm Myocardial infarction |
|
Taxanes | Paclitaxel Docetaxel |
Myocardial ischemia (55,56) Coronary vasospasm (109) |
|
Alkylating agents | Cyclophosphamide | Hemorrhagic myopericarditis |
|
Immune checkpoint inhibitors | Pembrolizumab Nivolumab Ipilimumab Atezolizumab |
Myocarditis (incidence 1%-2%) (84,110, 111, 112, 113, 114, 115, 116) Increased risk of coronary atherosclerosis (117) |
|
Vascular endothelial growth factor inhibitors | Bevacizumab Sunitinib Sorafenib Pozapanib |
Arterial hypertension Acute thromboembolic events (118, 119, 120, 121, 122) |
|
Anthracyclines | Doxorubicin Daunorubicin Idarubicin Mitoxantrone |
Cardiomyopathy Arrhythmia Pericardial effusion |
|
HER2/neu receptor inhibitors | Trastuzumab | Cardiomyopathy |
|
ACS = acute coronary syndrome; ASCVD = atherosclerotic cardiovascular disease; CAC = coronary artery calcium scoring; CT = computed tomography; CTA = computed tomography angiography; FU = fluorouracil.